FDA Completes Review of Hepzato Combo in HER2– Metastatic Breast Cancer
The FDA has completed its 30-day review of an application for Hepzato in combination with standard of care in liver-dominant metastatic breast cancer.
The FDA has completed its 30-day review of an application for Hepzato in combination with standard of care in liver-dominant metastatic breast cancer.
Read about how nursing unions have responded to the UK Supreme Court’s ruling on the definition of a woman under the Equality Act 2010.
Read about new recommendations from the World Health Organization to end the rise in “medicalised” female genital mutilation.
Joanna Martin on how children with medical complexity deserve equity in care and support.
As a child, Su Jeffreys felt that a career in healthcare was right for her. She tells us why she joined the Royal Navy and…
Dr. Matthew Galsky highlights the impact of Imfinzi’s adjuvant approval for patients with muscle-invasive bladder cancer following cystectomy and chemo.
Read about a new collaborative project between leaders in human and animal nursing aimed at reducing unnecessary glove use
Olufunke Adelaiye-Opebiy gives tips to early career nurses for effective communication strategies for working in the community. Read more.
Nursing Times Careers Plus 2025 – London (June)
Find out which governments across the UK will begin collecting data on corridor care taking place across hospitals.
Read about new recommendations from the World Health Organization to end the rise in “medicalised” female genital mutilation.